The North America OTC Drug and Dietary Supplement market was valued at US$ 131,818.3 million in 2019 and is projected to reach US$ 224,349.5 million by 2027; it is expected to grow at a CAGR of 7.0% during 2020–2027.
The growth of the OTC Drug and Dietary Supplement market is mainly attributed to the factors such as as rising awareness among population about general health issues, and advantages of OTC drugs are expected to propel the growth of the market. However, strict FDA regulation for OTC drugs is the major factor hindering the market growth.
The US has observed the fastest growth in the OTC Drug and Dietary Supplement market within the past few years and is expected to lead the market in North America during the forecast period. The country is the largest producer of pharmaceutical products and is a leading country for producing innovative drugs. Therefore, OTC drugs, prescribed drugs, and dietary supplements play a significant role in the US's healthcare system. The largest-selling OTC drug class in the US is upper respiratory remedies, oral analgesics, heartburn, antiperspirants, oral antiseptics and rinses, first aids, and beauty products.
US OTC Drug and Dietary Supplement Market Revenue and Forecast to 2027 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA OTC DRUG AND DIETARY SUPPLEMENT – MARKET SEGMENTATION
OTC drug and Dietary Supplement – By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Antacids
- Feminine Care
- Others
OTC Drug and Dietary Supplement– By Type
- Branded
- Generic
OTC Drug and Dietary Supplement– By Form
- Tablets
- Capsules
- Powders
- Ointments
- Liquid
- Others
OTC Drug and Dietary Supplement – By Distribution Channel
- Hospital and Retail Pharmacies
- Retail Stores
- Online Channels
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
North America OTC Drug and Dietary Supplement Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 131,818.3 Million |
| Market Size by 2027 | US$ 224,349.5 Million |
| Global CAGR (2020 - 2027) | 7.0% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Environmental Consulting Service Market
- Asset Integrity Management Market
- Aircraft Wire and Cable Market
- Battery Testing Equipment Market
- USB Device Market
- Transdermal Drug Delivery System Market
- Retinal Imaging Devices Market
- Hair Wig Market
- Travel Vaccines Market
- Batter and Breader Premixes Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Type, Form, Distribution Channel, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - North America OTC Drug and Dietary Supplement Market
- GlaxoSmithKline plc.
- Sanofi
- Johnson and Johnson Services, Inc.
- Abbott
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Procter & Gamble
- Novartis AG
- Reckitt Benckiser Group Plc
Get Free Sample For